This is a resubmission of a competing continuation application: R01 CA 63030. This proposal would test a behavioral and interdisciplinary triage team intervention for blood and marrow transplantation (BMT) survivors which is cost and resource conserving and can be made available to virtually any survivor. The proposed design is a randomized controlled clinical trial in a consortium, with national multi-site accrual (N= 386 accrued pretransplant; 230 surviving to one year follow-up). Family caregivers are accrued where identifiable. Based on our prior research, we have targeted the dominant areas of long-term concern for a majority of BMT survivors. The study prescribes intervention early, after patients return home to widely divergent community resources, and before problems develop into maladaptive patterns that sustain long-term impairments.
Specific aims are to determine whether the intervention package assists transplant recipients and their families in: 1) managing rehabilitation needs including reduced stamina and cognitive limitations; 2) adjusting to fluctuations in family roles and emotions; and 3) managing menopausal symptoms and sexual function changes (for women only). Male and female adult survivors, with a primary caregiver, will receive one of two interventions: I.) Standard Treatment consisting of usual discharge preparation at each BMT site prior to return home; or II.) An Intervention Package consisting of nine (for men) or ten (for women) psychoeducational telephone counseling sessions over the year after return home from transplant. Problems identified with the telephone counselor will be triaged for additional assessment and resource activation by a study nurse. Assessments include pre- and post-transplant baselines prior to randomization and intervention, with one and two year follow-up assessments to evaluate the intervention efficacy. Primary hypotheses include that survivors who participate in the intervention will have improved function in the targeted areas and that this improvement will be mediated through increased use of active coping strategies. This research builds directly on the work of the previous grant cycle by extending the prior specific aims to a wider group of patients through an improved methodology. The BMT setting provides a well-standardized environment in which to test interventions that will be applicable to both the ever-increasing numbers of transplantation survivors and other populations of cancer survivors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063030-06
Application #
6172217
Study Section
Behavioral Medicine Study Section (BEM)
Program Officer
Aziz, Noreen M
Project Start
1994-09-30
Project End
2003-05-31
Budget Start
2000-06-01
Budget End
2001-05-31
Support Year
6
Fiscal Year
2000
Total Cost
$662,180
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Syrjala, Karen L; Yi, Jean C; Langer, Shelby L (2016) Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients. Psychooncology 25:529-35
Fann, Jesse R; Hubbard, Rebecca A; Alfano, Catherine M et al. (2011) Pre- and post-transplantation risk factors for delirium onset and severity in patients undergoing hematopoietic stem-cell transplantation. J Clin Oncol 29:895-901
Syrjala, Karen L; Artherholt, Samantha B; Kurland, Brenda F et al. (2011) Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years. J Clin Oncol 29:2397-404
Basinski, James R; Alfano, Catherine M; Katon, Wayne J et al. (2010) Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant. Biol Blood Marrow Transplant 16:824-31
Kirchhoff, Anne C; Leisenring, Wendy; Syrjala, Karen L (2010) Prospective predictors of return to work in the 5 years after hematopoietic cell transplantation. J Cancer Surviv 4:33-44
Zaubler, Thomas; Fann, Jesse R; Roth-Roemer, Sari et al. (2010) Impact of delirium on decision-making capacity after hematopoietic stem-cell transplantation. Psychosomatics 51:320-9
Langer, Shelby L; Yi, Jean C; Storer, Barry E et al. (2010) Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five-year longitudinal investigation. Psychooncology 19:190-200
Yi, Jean C; Syrjala, Karen L (2009) Sexuality after hematopoietic stem cell transplantation. Cancer J 15:57-64
Syrjala, Karen L; Kurland, Brenda F; Abrams, Janet R et al. (2008) Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood 111:989-96
Syrjala, Karen L; Abrams, Janet R; Polissar, Nayak L et al. (2008) Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain 135:175-86

Showing the most recent 10 out of 22 publications